Serving Size: 1 Capsule... %DV
Boswellia serrata (5:1, 40% boswellic acids)... 333 mg... †
† Daily Value not established
What Is It?
Maxi Boz II is a standardized extract of the resin of Boswellia serrata, also known as Indian Frankincense, a botanical with a long historical usage in traditional Ayurvedic medicine to support joint inflammation and general inflammation.
What Does It Do?
Primary Uses: Boswellia reduces inflammation and pain in rheumatoid arthritis and osteoarthritis and has even been shown effective in reducing the severity of inflammatory intestinal disorders. Boswellia extracts are safer and more potent than conventional non-steroidal anti-inflammatory drugs (NSAIDs). Treatment with NSAIDs is a well-known contributing factor to articular degeneration. Supplementation with Boswellia serrata extract has been shown to prevent the degradation of glycosaminoglycan, one of the major constituents of cartilage.
Secondary Uses: Maxi Boz II can also be used to reduce mucous secretions in the lungs. Applications include emphysema, cystic fibrosis and chronic bronchitis among others.
Who Should Take It?
Whether you are suffering from aching joints, intestinal inflammation, acute or chronic inflammation due to irritation, injury or autoimmunity, Maxi Boz II is an excellent choice to help manage inflammation and to encourage recovery.
Take 1 capsule three times daily with food, or as directed by a qualified health care practitioner.
CAUTION: Consult a health care practitioner before use if you are pregnant or breastfeeding. Some people may experience mild gastrointestinal effects such as diarrhea, abdominal pain/cramps and nausea.
Ammon HP, Mack T, Singh GB, Safayhi H. (1991) “
Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum-resin exudate of Boswellia Serrata”
. Planta-Med; 57: 203.
Atal CK, et al (1984) “
Salai guggal a new NSAID and its probable mode of action”
Recent advances in Mediators Inflammation and Anti inflammatory Agents. Symp. Nov 2-4.
Gupta I, Gupta V, Parihar A, Gupta S, Ludtke R, Safayhi H, Ammon HP. “
Effects of Boswellia serrata gum resin in patients with bronchial asthma: results of a double-blind, placebo-controlled, 6-week clinical study.”
Eur J Med Res 1998 Nov 17; 3(11): 511-4.
Gupta I, Parihar A, Malhotra P, Singh GB, Ludtke R, Safayhi H, Ammon HP. “
Effects of Boswellia serrata gum resin in patients with ulcerative colitis.”
Eur J Med Res 1997 Jan; 2(1): 37-43.
Kimmatkar N, Thawani V, Hingorani L, Khiyani R. “
Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial.”
Phytomedicine 2003 Jan; 10(1): 3-7.
Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B. (1991) “
Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled study”
. J. Ethanopharmacol; 33:91.v. 11th European Congress of Rheumatology Vol 5/8-2 Suppl. Issue 1987.
Menon MK, Kar A. (1971) “
Analgesic and Psychopharmacological effects of gum resin of Boswellia Serrata”
Planta Medica; 19: 332-336.
Reddy GK, Chandrakasan G, Dhar SC. (1981) “
Studies on the metabolism of glycoaminoglycalls under the influence of new herbal anti-inflammatory agents”
. Biochemical Pharmacol., 38 3527 1989.
Reddy GK, et al (1988) “
Effect of Salai guggal ex-Boswellia Serrata on cellular and humoral immune responses and leucocyte migration. “
Agents and Action; 24: 161.
Safayhi H, et al (1992) “
Boswellic acids: novel, specific, non-redox inhibitors of 5-lipooxygenase”
. J. Pharmacol. Exp. Ther; 261: 1143.
Sengupta et al. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin® for treatment of osteoarthritis of the knee. Arthritis Research and Therapy. 2008; 10: R85
Sharma ML, Kaul A, Khajuria A, Singh S, Singh GB. “
Immunomodulatory Activity of Boswellic Acids (Pentacyclic Triterpene Acids) from Boswellia serrata.”
Phytother Res. 1996 Mar; 10(2): 107-12.
Singh GB, Atal CK. (1990) “
Pharmacology of an extract of Boswellia Serrata, a new non-steroidal anti-inflammatory agent”
. Agents Action; 18: 407-412.
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.